134 related articles for article (PubMed ID: 3278912)
1. CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells.
Bergui L; Tesio L; Schena M; Riva M; Malavasi F; Schulz T; Marchisio PC; Caligaris-Cappio F
Eur J Immunol; 1988 Jan; 18(1):89-96. PubMed ID: 3278912
[TBL] [Abstract][Full Text] [Related]
2. Immunobiology of chronic lymphocytic leukemia.
Freedman AS
Hematol Oncol Clin North Am; 1990 Apr; 4(2):405-29. PubMed ID: 2182599
[TBL] [Abstract][Full Text] [Related]
3. Genetic influence on the levels of circulating CD5 B lymphocytes.
Kipps TJ; Vaughan JH
J Immunol; 1987 Aug; 139(4):1060-4. PubMed ID: 3112220
[TBL] [Abstract][Full Text] [Related]
4. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
5. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
6. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
10. Relationship between different cell surface markers in chronic lymphocytic leukemia.
Potomski J; Harłozińska A; Becker M; Noworolska A
Neoplasma; 1980; 27(3):295-300. PubMed ID: 7453849
[TBL] [Abstract][Full Text] [Related]
11. [Heterogeneity of surface antigens in chronic B-cell lymphoid leukemia].
Pálóczi K; Benczúr M; Mihalik R; Solti V; Hollán Z
Orv Hetil; 1991 Jan; 132(1):7-8, 11-3. PubMed ID: 1987510
[TBL] [Abstract][Full Text] [Related]
12. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
[TBL] [Abstract][Full Text] [Related]
13. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice.
Novelli EM; Ramírez M; Leung W; Civin CI
Stem Cells; 1999; 17(5):242-52. PubMed ID: 10527459
[TBL] [Abstract][Full Text] [Related]
14. Modulation of chronic lymphocytic leukemia (CLL) lymphocyte phenotypes by in vitro incubation with alpha 1 thymosin.
Benković B; Burek B; Jaksić B; Vitale B
Blood Cells; 1987; 12(2):441-55. PubMed ID: 3304472
[TBL] [Abstract][Full Text] [Related]
15. Intraclonal diversity in the VH genes expressed by CD5- chronic lymphocytic leukemia-producing pathologic IgM rheumatoid factor.
Roudier J; Silverman GJ; Chen PP; Carson DA; Kipps TJ
J Immunol; 1990 Feb; 144(4):1526-30. PubMed ID: 1689356
[TBL] [Abstract][Full Text] [Related]
16. IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain.
Weston KM; Tangye SG; Dunn RD; Smith A; Morris MB; Raison RL
J Mol Recognit; 2001; 14(4):245-53. PubMed ID: 11500971
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
Han T; Ozer H; Minowada J
Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
[TBL] [Abstract][Full Text] [Related]
18. CD5-positive B-cells of the fetal and adult spleen lymphoid tissue: an immunophenotypical study.
Valente G; Geuna M; Novero D; Arisio R; Palestro G; Stramignoni A
Verh Dtsch Ges Pathol; 1990; 74():155-8. PubMed ID: 1708575
[TBL] [Abstract][Full Text] [Related]
19. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
Kansas GS; Tedder TF
J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]